PortfoliosLab logoPortfoliosLab logo
JNJ vs. GRMN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JNJ vs. GRMN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Johnson & Johnson (JNJ) and Garmin Ltd. (GRMN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JNJ achieves a 28.69% return, which is significantly higher than GRMN's 20.80% return. Over the past 10 years, JNJ has underperformed GRMN with an annualized return of 10.71%, while GRMN has yielded a comparatively higher 21.12% annualized return.


JNJ

1D
1.59%
1M
9.29%
6M
20.98%
YTD
28.69%
1Y
59.22%
3Y*
18.59%
5Y*
12.03%
10Y*
10.71%
ALL TIME*
12.34%

GRMN

1D
1.22%
1M
1.25%
6M
18.85%
YTD
20.80%
1Y
6.61%
3Y*
34.06%
5Y*
11.91%
10Y*
21.12%
ALL TIME*
16.29%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$211.14M$200.14M$201.29M
$2.16B$2.18B$1.96B

JNJ vs. GRMN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
JNJ
Johnson & Johnson
28.69%47.48%-4.81%-8.58%5.97%11.44%10.82%16.22%-5.13%24.43%
GRMN
Garmin Ltd.
20.80%-0.06%63.25%43.12%-30.20%15.90%25.86%58.13%9.84%27.60%

Correlation

The correlation between JNJ and GRMN is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Dec 12, 2000

0.25

Over the past year, the correlation between JNJ and GRMN has dropped to 0.04 - well below their long-term average of 0.25, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

JNJ:

$634.06B

GRMN:

$46.88B

EPS

JNJ:

$8.63

GRMN:

$8.97

PE Ratio

JNJ:

30.53

GRMN:

27.10

PEG Ratio

JNJ:

1.02

GRMN:

2.18

PS Ratio

JNJ:

6.56

GRMN:

6.30

PB Ratio

JNJ:

7.56

GRMN:

5.07

Total Revenue (TTM)

JNJ:

$97.93B

GRMN:

$7.46B

Gross Profit (TTM)

JNJ:

$68.99B

GRMN:

$4.41B

EBITDA (TTM)

JNJ:

$31.92B

GRMN:

$2.26B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JNJ vs. GRMN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JNJ
JNJ Risk / Return Rank: 9797
Overall Rank
JNJ Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
JNJ Sortino Ratio Rank: 9898
Sortino Ratio Rank
JNJ Omega Ratio Rank: 9797
Omega Ratio Rank
JNJ Calmar Ratio Rank: 9595
Calmar Ratio Rank
JNJ Martin Ratio Rank: 9696
Martin Ratio Rank

GRMN
GRMN Risk / Return Rank: 5353
Overall Rank
GRMN Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
GRMN Sortino Ratio Rank: 4949
Sortino Ratio Rank
GRMN Omega Ratio Rank: 5050
Omega Ratio Rank
GRMN Calmar Ratio Rank: 5454
Calmar Ratio Rank
GRMN Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JNJ vs. GRMN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Garmin Ltd. (GRMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JNJGRMNDifference
Sharpe ratioReturn per unit of total volatility

+3.07

Sortino ratioReturn per unit of downside risk

+3.99

Omega ratioGain probability vs. loss probability

1.56

1.07

+0.49

Calmar ratioReturn relative to maximum drawdown

5.43

0.24

+5.19

Martin ratioReturn relative to average drawdown

15.17

0.50

+14.66

JNJ vs. GRMN - Sharpe Ratio Comparison

The current JNJ Sharpe Ratio is 3.28, which is higher than the GRMN Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of JNJ and GRMN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JNJ vs. GRMN - Drawdown Comparison

The maximum JNJ drawdown since its inception was -50.67%, smaller than the maximum GRMN drawdown of -87.71%. Use the drawdown chart below to compare losses from any high point for JNJ and GRMN.


Loading charts...

Drawdown Indicators


JNJGRMNDifference

Max Drawdown

Largest peak-to-trough decline

-50.67%

-87.71%

+37.04%

Max Drawdown (1Y)

Largest decline over 1 year

-10.96%

-27.97%

+17.01%

Max Drawdown (3Y)

Largest decline over 3 years

-15.95%

-27.97%

+12.02%

Max Drawdown (5Y)

Largest decline over 5 years

-18.41%

-54.63%

+36.22%

Max Drawdown (10Y)

Largest decline over 10 years

-27.37%

-54.63%

+27.26%

Current Drawdown

Current decline from peak

-1.44%

-8.75%

+7.31%

Average Drawdown

Average peak-to-trough decline

-11.88%

-31.44%

+19.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.92%

13.20%

-9.28%

Volatility

JNJ vs. GRMN - Volatility Comparison

Johnson & Johnson (JNJ) has a higher volatility of 8.75% compared to Garmin Ltd. (GRMN) at 7.60%. This indicates that JNJ's price experiences larger fluctuations and is considered to be riskier than GRMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JNJGRMNDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.75%

7.60%

+1.15%

Volatility (6M)

Calculated over the trailing 6-month period

14.62%

22.16%

-7.54%

Volatility (1Y)

Calculated over the trailing 1-year period

18.12%

30.48%

-12.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.37%

30.55%

-13.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.71%

28.33%

-9.62%

Dividends

JNJ vs. GRMN - Dividend Comparison

JNJ's dividend yield for the trailing twelve months is around 1.99%, more than GRMN's 1.54% yield.


PositionTTM20252024202320222021202020192018201720162015
GRMN
Garmin Ltd.
1.54%1.70%1.44%2.27%3.10%1.92%2.01%2.30%3.32%3.42%4.21%5.41%
JNJ
Johnson & Johnson
1.99%2.48%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%

Financials

JNJ vs. GRMN - Financials Comparison

This section allows you to compare key financial metrics between Johnson & Johnson and Garmin Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00B25.00B20222023202420252026
25.31B
1.75B
(JNJ) Total Revenue
(GRMN) Total Revenue
Values in USD except per share items

JNJ vs. GRMN - Profitability Comparison

The chart below illustrates the profitability comparison between Johnson & Johnson and Garmin Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

55.0%60.0%65.0%70.0%20222023202420252026
73.1%
59.4%
Portfolio components
JNJ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a gross profit of 18.50B and revenue of 25.31B. Therefore, the gross margin over that period was 73.1%.

GRMN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Garmin Ltd. reported a gross profit of 1.04B and revenue of 1.75B. Therefore, the gross margin over that period was 59.4%.

JNJ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported an operating income of 7.17B and revenue of 25.31B, resulting in an operating margin of 28.3%.

GRMN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Garmin Ltd. reported an operating income of 431.67M and revenue of 1.75B, resulting in an operating margin of 24.6%.

JNJ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Johnson & Johnson reported a net income of 5.53B and revenue of 25.31B, resulting in a net margin of 21.9%.

GRMN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Garmin Ltd. reported a net income of 405.08M and revenue of 1.75B, resulting in a net margin of 23.1%.


Frequently Asked Questions


JNJ and GRMN have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JNJ has higher volatility (8.75%) compared to GRMN (7.60%). In terms of maximum drawdown, JNJ dropped -50.67% vs GRMN's -87.71%.

JNJ currently has the higher Sharpe Ratio (3.28 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JNJ and GRMN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer